Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04135846
PHASE2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Sponsor: Brown University
View on ClinicalTrials.gov
Summary
The goal of this research is to replicate findings previously conducted in a pilot trial and to understand, mechanistically, the role of stress in the development of AUD pharmacotherapies that target noradrenergic blockade.
Official title: A Focus on Alpha-1 Blockade as a Novel Pharmacological Treatment for AUD
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
184
Start Date
2019-12-19
Completion Date
2026-08-31
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
DRUG
Doxazosin
16 mg or maximum tolerated dose (MTD)
DRUG
Placebo
Matching placebo
Locations (1)
Brown University
Providence, Rhode Island, United States